可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Stauffer NR,Murphy K.Prenatal diagnosis of congenital heart disease:the beginning[J]. Crit Care Nurs Q,2002,25(3):1-7.
[2] 王晖,杨志健,马根山,等. 血管紧张素Ⅱ1型受体基因多态性与冠状动脉血管病变及支架内再狭窄的关系[J].心脏杂志,2003,15(4):303-305.
[3] 张莉莉,吕安林,王海昌,等. 载脂蛋白E基因多态性与冠心病相关因素的关联性[J].心脏杂志,2004,16(3):252-254.
[4] 谢学健,郭文怡,李兰荪,等. Connexin 37个基因多态性与冠心病的相关性[J].心脏杂志,2006,18(5):539-541.
[5]Akazawa H,Komuro I. Cardiac transcription factor Nkx2.5: Its role in cardiac development and diseases[J]. Pharmacol Ther,2005,107(2):252-268.
[6] Koizumi K, Lintas C, Nirenberg M,et al.Mutations that affect the ability of the vnd/NK2 homeoprotein to regulate gene expression:Transgenic alterations and tertiary structure[J].Proc Natl Acad Sci U S A,2003,100(6):3119-3124.
[7] McElhinney DB,Geiger E, Blinder J,et al.Nkx2.5 mutations in patients with congenital heart diease[J]. J Am Coll Cardiol,2003,42(9):1650-1655.
[8] ReamonBuettner SM,Borlak J. GATA4 zinc finger mutations as a molecular rationale for septation defects of the human heart[J].J Med Genet,2005,42(5):e32.
[9] Elliott DA, Kirk EP, Yeoh T, et a1.Cardiac homeobox gene NKX2.5 mutations and congenital heart disease: associations with atrial septal defect and hypoplastic left heart syndrome[J]. J Am Coll Cardiol,2003,41(11):2072-2076.
[10]Zang MX,Li Y, Xue LX,et al. Cooperative activation of atrial natriuretic peptide promoter by dHAND and MEF2C[J].J Cell Biochem,2004,93(6):1255-1266.
[11]石琳,申阿东,李晓峰,等.中国先天性心脏病Nkx2.5基因突变筛查及关联研究[J].首都医科大学学报,2005,26(5):525-528.
[12]ReamonBuettner SM,Hecker H, SpanelBorowski K,et al.Novel Nkx2.5 mutation in diseased heart tissues of patients with cardiac malformations[J].Am J Pathol,2004,164(6):2117~2125.